Cue Biopharma, Inc. (CUE)
NASDAQ
Cue Biopharma, Inc. Income Statement 2018–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenue | 27.5M | 9.3M | 5.5M | 1.2M | 14.9M | 3.2M | 3.5M | 1.1M |
| Gross Profit | — | — | — | — | — | — | — | — |
| Profitability | ||||||||
| Operating Income | -26.6M | -41.5M | -52.1M | -53.2M | -43.7M | -45.0M | -36.8M | -38.7M |
| EBITDA | -25.6M | -41.1M | -51.6M | -52.3M | -42.5M | -44.0M | -36.0M | -37.9M |
| Net Income | -26.6M | -40.7M | -50.7M | -53.0M | -44.2M | -44.8M | -36.7M | -39.0M |
| Per Share Data | ||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 95M | 56M | 46M | 36M | 31M | 30M | 27M | 21M |
Cue Biopharma, Inc. Income Statement — FAQ
Cue Biopharma, Inc. (CUE) income statement over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CUE's income statement history?
The chart and table above show Cue Biopharma, Inc.'s income statement by year and by quarter, including the growth rate.